Abstract:AIMS:Although programmed cell death protein 1 (PD-1) typically serves as a target for immunotherapies, a few recent studies have found that PD-1 is expressed in the nervous system and that neuronal PD-1 might play a crucial role in regulating neuronal excitability. However, whether brain-localized PD-1 is involved in seizures and epileptogenesis is still unknown and worthy of in-depth exploration.METHODS:The existence of PD-1 in human neurons was confirmed by immunohistochemistry, and PD-1 expression levels were measured by real-time quantitative PCR (RT-qPCR) and western blotting. Chemoconvulsants, pentylenetetrazol (PTZ) and cyclothiazide (CTZ), were applied for the establishment of in vivo (rodents) and in vitro (primary hippocampal neurons) models of seizure, respectively. SHR-1210 (a PD-1 monoclonal antibody) and sodium stibogluconate (SSG, a validated inhibitor of SH2-containing protein tyrosine phosphatase-1 [SHP-1]) were administrated to investigate the impact of PD-1 pathway blockade on epileptic behaviors of rodents and epileptiform discharges of neurons. A miRNA strategy was applied to determine the impact of PD-1 knockdown on neuronal excitability. The electrical activities and sodium channel function of neurons were determined by whole-cell patch-clamp recordings. The interaction between PD-1 and α-6 subunit of human voltage-gated sodium channel (Nav1.6) was validated by performing co-immunostaining and co-immunoprecipitation (co-IP) experiments.RESULTS:Our results reveal that PD-1 protein and mRNA levels were upregulated in lesion cores compared with perifocal tissues of surgically resected specimens from patients with intractable epilepsy. Furthermore, we show that anti-PD-1 treatment has anti-seizure effects both in vivo and in vitro. Then, we reveal that PD-1 blockade can alter the electrophysiological properties of sodium channels. Moreover, we reveal that PD-1 acts together with downstream SHP-1 to regulate sodium channel function and hence neuronal excitability. Further investigation suggests that there is a direct interaction between neuronal PD-1 and Nav1.6.CONCLUSION:Our study reveals that neuronal PD-1 plays an important role in epilepsy and that anti-PD-1 treatment protects against seizures by suppressing sodium channel function, identifying anti-PD-1 treatment as a novel therapeutic strategy for epilepsy.

The Apelin/APJ system modulates seizure activity and endocytosis of the NMDA receptor GluN2B subunit

A Purinergic P2 Receptor Family-Mediated Increase in Thrombospondin-1 Bolsters Synaptic Density and Epileptic Seizure Activity in the Amygdala-Kindling Rat Model

P2Y4/TSP-1/TGF-β1/pSmad2/3 Pathway Contributes to Acute Generalized Seizures Induced by Kainic Acid

Endophilin A1 mediates seizure activity via regulation of AMPARs in a PTZ-kindled epileptic mouse model

Inhibition of ANXA2 activity attenuates epileptic susceptibility and GluA1 phosphorylation

Apelin/APJ system: an emerging therapeutic target for neurological diseases

Role of Elevated Thrombospondin-1 in Kainic Acid-Induced Status Epilepticus.

Neuropeptide apelin presented in the dopaminergic neurons modulates the neuronal excitability in the substantia nigra pars compacta

Inhibition of Nwd1 activity attenuates neuronal hyperexcitability and GluN2B phosphorylation in the hippocampus

Elevated Expression of Acid-Sensing Ion Channel 3 Inhibits Epilepsy Via Activation of Interneurons

Enhancing Glymphatic Fluid Transport by Pan-Adrenergic Inhibition Suppresses Epileptogenesis in Male Mice

Anti-PD-1 Treatment Protects Against Seizure by Suppressing Sodium Channel Function

Blocking ERK-DAPK1 Axis Attenuates Glutamate Excitotoxicity in Epilepsy

Apelin-13/APJ system attenuates early brain injury via suppression of endoplasmic reticulum stress-associated TXNIP/NLRP3 inflammasome activation and oxidative stress in a AMPK-dependent manner after subarachnoid hemorrhage in rats

Effect of Connexin 36 Blockers on the Neuronal Cytoskeleton and Synaptic Plasticity in Kainic Acid-Kindled Rats

Conditional Knockout of ASK1 in Microglia/macrophages Attenuates Epileptic Seizures and Long-Term Neurobehavioural Comorbidities by Modulating the Inflammatory Responses of Microglia/macrophages

Adenosine A1 Receptors Play an Important Protective Role Against Cognitive Impairment and Long-Term Potentiation Inhibition in a Pentylenetetrazol Mouse Model of Epilepsy.

Blockade of Kv1.3 Potassium Channel Inhibits Microglia-Mediated Neuroinflammation in Epilepsy

Dl-3n-butylphthalide reduces epileptiform activity through GluA2-lacking calcium-permeable AMPARs in epilepsy models

Kallikrein-kinin system and epileptogenesis

The Expression of G Protein-Coupled Receptor Kinase 5 and Its Interaction with Dendritic Marker Microtubule-Associated Protein-2 after Status Epilepticus